-+ 0.00%
-+ 0.00%
-+ 0.00%

PFIZER’S TUKYSA REGIMEN RECEIVES FDA APPROVAL AS FRONT-LINE MAINTENANCE TREATMENT FOR HER2+ METASTATIC BREAST CANCER

Reuters·10/07/2026 16:59:14